OCT West Coast: key points on engaging patients and advocacy groups
Bringing power to the patient in all areas of healthcare and research has become one of the fastest growing concepts…
Latest Outsourcing
-
5 days
-
1 week
-
6 months
-
9 months
-
5 days
-
1 week
-
6 months
-
9 months
OCT West Coast: IQVIA’s Nagaraja Srivatsan talks decentralised trials and the future of clinical research
Throughout the Covid-19 pandemic, decentralised clinical trials have become ever more prevalent in the clinical research field, and their uptake…
Latest News
View More
Poor Communication Can Cost You – REALLY Cost You
Believing that because you are telling people things all day long, you are communicating with people can sink you faster than you might believe possible.…
The Stem Cell Emperor’s New Clothes
For some time now, the potential of the global stem cell clinical supply industry has been undermined by a human foible captured in a Hans…
Announcing ‘The Return of Outsourcing Week’ on Clinical Trials Arena
As Arena International’s Outsourcing in Clinical Trials New England conference gets underway this week in Boston, Massachusetts, Clinical Trials Arena…
Clinical Trials in the US Midwest: Looking Back
This week in Chicago, IL, Arena International’s Outsourcing in Clinical Trials Midwest conference gets underway for its third edition. Following…
The Top 5: July 2018
There were numerous articles in July 2018 that covered a wide range of topical issues. Here are five of the…
Announcing ‘Outsourcing Week’ on Clinical Trials Arena
As Arena International’s Outsourcing in Clinical Trials Europe conference gets underway this week in Barcelona, Spain, Clinical Trials Arena will…
Company A-Z
View More
VaLea Clinical Trials
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
Latest Content
View More
How to Enable Greater Budget Forecasting
It is often said there are two types of budget forecasting, lucky and wrong. The art of true forecasting is…
To Outsource or Not to Outsource? That is the Question
As a small to medium-sized company, the decision regarding how to outsource your clinical trial activities requires a fully informed…
COSELA™ (trilaciclib) for the Treatment of Chemotherapy-Induced Myelosuppression, US
COSELA™ (trilaciclib) is the first approved myeloprotection therapy indicated to reduce the occurrence of chemotherapy-induced bone marrow suppression in adult…
UKONIQ™ (umbralisib) for the Treatment of Marginal Zone Lymphoma (MZL) and Follicular Lymphoma (FL)
UKONIQ™ (umbralisib) is the first and only oral, dual inhibitor of phosphoinositide 3 kinase (PI3K) delta and casein kinase 1…
New Warehouse Construction at Staufen Headquarters
In the past few months, two new warehouses were erected and put into operation on the IKA premises. IKA continues…